Accord Biosciences Receives $1.3M NIH SBIR Grant To Develop Pulmonary Hypertension Diagnostic
Last year, Accord Biosciences was awarded a Phase II National Institutes of Health Small Business Innovation Research grant of $1.3M to develop a point-of-care diagnostic for pulmonary arterial hypertension.